XML 41 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Cash Cash Equivalents And Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets to the amount reported in the Consolidated Statement of Cash Flows for the years ended December 31, 2022 and 2021 (in thousands).

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

11,834

 

 

$

24,361

 

Restricted cash

 

 

761

 

 

 

811

 

Cash, cash equivalents and restricted cash in the consolidated statements of cash flows

 

$

12,595

 

 

$

25,172

 

Schedule of Dilutive Securities Excluded from Computation of Income (Loss) Per Share

The following outstanding potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their impact under the treasury stock method was anti-dilutive for the periods presented:

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Stock options issued and outstanding under the Calhoun Vision, Inc. 2006 Stock Plan, Calhoun Vision, Inc. 2015 Equity Incentive Plan and the 2021 Equity Incentive Plan

 

 

1,926,226

 

 

 

2,144,860

 

Restricted stock units

 

 

543,538

 

 

 

223,716

 

Stock issuable in offering period under the 2021 Employee Stock Purchase Plan

 

 

48,594

 

 

 

8,248

 

Schedule of Revenue from Contracts with Customers

For the years ended December 31, 2022 and 2021, contract liabilities from sales activity recorded as liabilities on the Company's consolidated balance sheets consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

540

 

 

$

345

 

 

Additions during the period

 

 

2,052

 

 

 

793

 

 

Revenue recognized during the period

 

 

(1,405

)

 

 

(598

)

 

Balance at end of period

 

$

1,187

 

 

$

540